Literature DB >> 15769461

Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice.

Lianne S M Boesten1, A Susanne M Zadelaar, Anita van Nieuwkoop, Marion J J Gijbels, Menno P J de Winther, Louis M Havekes, Bart J M van Vlijmen.   

Abstract

OBJECTIVE: Tumor necrosis factor-alpha (TNFalpha) is a pleiotropic cytokine exerting both inflammatory and cell death modulatory activity, and is thought to play a role in the pathogenesis of atherosclerosis. Studies in mice indicated that TNFalpha affects atherosclerosis minimally or not under conditions that allow fatty streak formation. Here, we examined the possible role of TNFalpha in advanced and complex atherosclerotic lesions. METHODS AND
RESULTS: To induce atherosclerosis, TNFalpha-deficient (Tnf-/-) APOE*3-Leiden and control APOE*3-Leiden only mice were fed a cholesterol-rich diet. Comparable levels of plasma cholesterol and triglycerides and the systemic inflammatory parameters, serum amyloid A and soluble intercellular adhesion molecule-1 were found in APOE*3-LeidenTnf-/- and control mice. Although absence of TNFalpha did not affect the quantitative area of atherosclerosis, APOE*3-LeidenTnf-/- mice had a higher relative number of early lesions (46.1% vs. 21.4%) and a lower relative number of advanced lesions (53.9% vs. 78.6%, P=0.04). In addition, the advanced lesions in APOE*3-LeidenTnf-/- mice showed less necrosis (9.9+/-12.1% vs. 23.4+/-19.3% of total lesion area, P=0.04) and an increase in apoptosis (1.5+/-1.5% vs. 0.4+/-0.6% of total nuclei, P=0.03).
CONCLUSIONS: Our data indicate that TNFalpha stimulates the formation of lesions towards an advanced phenotype, with more lesion necrosis and a lower incidence of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15769461     DOI: 10.1016/j.cardiores.2005.01.001

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  35 in total

1.  Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity.

Authors:  Pedro Melgar-Lesmes; Fernando Garcia-Polite; Paula Del-Rey-Puech; Elisabet Rosas; Juliana L Dreyfuss; Eulàlia Montell; Josep Vergés; Elazer R Edelman; Mercedes Balcells
Journal:  Atherosclerosis       Date:  2015-12-13       Impact factor: 5.162

2.  TNFα and Reactive Oxygen Signaling in Vascular Smooth Muscle Cells in Hypertension and Atherosclerosis.

Authors:  Fred S Lamb; Hyehun Choi; Michael R Miller; Ryan J Stark
Journal:  Am J Hypertens       Date:  2020-10-21       Impact factor: 2.689

Review 3.  Adipokines: a link between obesity and cardiovascular disease.

Authors:  Kazuto Nakamura; José J Fuster; Kenneth Walsh
Journal:  J Cardiol       Date:  2013-12-16       Impact factor: 3.159

4.  The SCFFBXO3 ubiquitin E3 ligase regulates inflammation in atherosclerosis.

Authors:  Divay Chandra; James Londino; Shaun Alexander; Joseph S Bednash; Yingze Zhang; Robert M Friedlander; Grant Daskivich; Diane L Carlisle; William R Lariviere; Ana Carolina Igami Nakassa; Mark Ross; Claudette St Croix; Toru Nyunoya; Frank Sciurba; Bill Chen; Rama K Mallampalli
Journal:  J Mol Cell Cardiol       Date:  2018-11-16       Impact factor: 5.000

5.  Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions.

Authors:  Brittany G Durgin; Olga A Cherepanova; Delphine Gomez; Themistoclis Karaoli; Gabriel F Alencar; Joshua T Butcher; Yu-Qing Zhou; Michelle P Bendeck; Brant E Isakson; Gary K Owens; Jessica J Connelly
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-10       Impact factor: 4.733

6.  Chondroitin Sulphate Attenuates Atherosclerosis in ApoE Knockout Mice Involving Cellular Regulation of the Inflammatory Response.

Authors:  Pedro Melgar-Lesmes; Alvaro Sánchez-Herrero; Ferran Lozano-Juan; Jose María de la Torre Hernández; Eulàlia Montell; Wladimiro Jiménez; Elazer R Edelman; Mercedes Balcells
Journal:  Thromb Haemost       Date:  2018-06-06       Impact factor: 5.249

7.  Interleukin-27 enhances TNF-α-mediated activation of human coronary artery endothelial cells.

Authors:  Huai-Na Qiu; Bin Liu; Weihua Liu; Shiming Liu
Journal:  Mol Cell Biochem       Date:  2015-09-19       Impact factor: 3.396

8.  USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis.

Authors:  Pierre-Yves Jean-Charles; Jiao-Hui Wu; Lisheng Zhang; Suneet Kaur; Igor Nepliouev; Jonathan A Stiber; Leigh Brian; Rui Qi; Virginia Wertman; Sudha K Shenoy; Neil J Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

9.  Expanded network of inflammatory markers of atherogenesis: where are we now?

Authors:  Seyed Hesameddin Abbasi; Mohammad Ali Boroumand
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

10.  Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice.

Authors:  Sofia Xanthoulea; Melanie Thelen; Chantal Pöttgens; Marion J J Gijbels; Esther Lutgens; Menno P J de Winther
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.